Previous studies have shown that hepatitis C virus (HCV) enters human hepatic cells through interaction with a series of cellular receptors, followed by
clathrin-mediated, pH-dependent endocytosis. Here, we investigated the mechanisms of HCV entry into multiple HCV-permissive human hepatocyte-derived cells using trans-complemented HCV particles (HCVtcp). Knockdown of CD81 and
claudin-1, or treatment with
bafilomycin A1, reduced
infection in Huh-7 and Huh7.5.1 cells, suggesting that HCV entered both cell types via receptor-mediated, pH-dependent endocytosis. Interestingly, knockdown of the
clathrin heavy chain or
dynamin-2 (Dyn2), as well as expression of the dominant-negative form of Dyn2, reduced
infection of Huh-7 cells with HCVtcp, whereas infectious entry of HCVtcp into Huh7.5.1 cells was not impaired.
Infection of Huh7.5.1 cells with culture-derived HCV (HCVcc) via a
clathrin-independent pathway was also observed. Knockdown of
caveolin-1,
ADP-ribosylation factor 6 (Arf6),
flotillin,
p21-activated kinase 1 (PAK1) and the PAK1 effector
C-terminal binding protein 1 of E1A had no inhibitory effects on HCVtcp
infection into Huh7.5.1 cells, thus suggesting that the infectious entry pathway of HCV into Huh7.5.1 cells was not caveolae-mediated, or Arf6- and
flotillin-mediated endocytosis and macropinocytosis, but rather may have occurred via an undefined endocytic pathway. Further analysis revealed that HCV entry was
clathrin- and
dynamin-dependent in ORL8c and HepCD81/miR122 cells, but productive entry of HCV was
clathrin- and
dynamin-independent in Hep3B/miR122 cells. Collectively, these data indicated that HCV entered different target cells through different entry routes.